T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,320.00
+20.00 (0.87%)
Oct 2, 2026, 3:30 PM KST
T&R Biofab Revenue
T&R Biofab had revenue of 9.54B KRW in the quarter ending June 30, 2026, with 45.88% growth. This brings the company's revenue in the last twelve months to 32.73B, up 120.91% year-over-year. In the year 2025, T&R Biofab had annual revenue of 26.97B with 453.32% growth.
Revenue (ttm)
32.73B
Revenue Growth
+120.91%
P/S Ratio
3.35
Revenue / Employee
380.61M
Employees
n/a
Market Cap
109.62B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 26.97B | 22.09B | 453.32% |
| Dec 31, 2024 | 4.87B | -325.47M | -6.26% |
| Dec 31, 2023 | 5.20B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.